Lots of jealous competitors and non GILD investors that obviously underestimated Sovaldi sales and product acceptance by providers. All of the negative chatter in the marketplace is noise. The cost issue is bogus though it makes for a nice "Obama like moment". I'm buyin the dips and making off like a bandit.